Talk Clinical Trials Innovation track
S0104 - ACT EU: Accelerating Clinical Trials in Europe through partnership
Wed, Mar 19, 2025 · 4:50–6:00 PM CET San Francisco Room, Congress Center Basel
About this session
With the transition to the Clinical Trials Regulation complete, ACT EU's vision for better, faster, and optimised clinical trials is taking shape. But making Europe more competitive requires all of us. How can we fully leverage our collective strengths? Let’s explore the opportunities and drive meaningful change together.
Programme:
- 2. CTCG Pre-CTA Advice Pilot– Rapid Regulatory Advice across EU/EEA MSs — Marianne Lunzer
- 1. Accelerating Clinical Trials in Europe through partnership - The ACT EU workplan — Ana Zanoletty Perez
- 3. Call to action: can patient groups contribute to make the EU more attractive for clinical trials? — François Houyez
- 4. Industry Perspective — Max Dr. Wegner
- 5. Commission Perspective — Elmar Nimmesgern
- Panel Discussion — Elmar Nimmesgern, Max Dr. Wegner, François Houyez, Marianne Lunzer, Ana Zanoletty Perez
Speakers
-
Treatment Information and Access Director, Health Policy Advisor · European Organisation for Rare Diseases (EURORDIS)
Speaker
-
Head of Clinical Trials Transformation Workstream · European Medicines Agency
Chair
